Single vial formulation of Taxotere approved - ONA
Links shared publicly online about this topic.
- 970total visits
Single vial formulation of Taxotere approved - ONA
Sanofi-aventis announced that the FDA has approved a one-vial formulation of Taxotere (docetaxel injection concentrate).
View full resource at oncologynurseadvisor.com
Tags: Cancer Medication, FDA, Taxotere, Sanofi-Aventis
Most Recently Shared on August 5, 2010 at 2:55 pm By:
Single vial formulation of Taxotere approved http://goo.gl/fb/U7lXX
FDA Approves Generic Docetaxel Injection from Hospira - MPR
empr.com — “The FDA has approved a single-vial formulation of docetaxel injection from Hospira, a generic version of Taxotere (sanofi-aventis).” View full resource at empr.com
Most Recently Shared on March 10, 2011 at 3:53 pm By:
MPR News: FDA Approves Generic Docetaxel Injection from Hospira: The FDA has approved a single-vial formulation ... http://bit.ly/iiOSPR
Advertisement
